Dracen Pharmaceuticals, Inc.
PrivateLast Round
Debt
Jul 27, 2023
Total Funding Raised
$61.8M
Company Overview
Dracen Pharmaceuticals, Inc. is a biotechnology company that develops cancer treatment medicines intended to shrink tumors and remodel the tumor microenvironment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dracen Pharmaceuticals, Inc. Comparables
Compare Dracen Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmunoMet Therapeutics | 81% | |
| Cornerstone Pharmaceuticals, Inc. | 77% | |
| Rafael Holdings, Inc. | 76% |
Dracen Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 27, 2023 | ||||
| Series A Extension | Mar 10, 2022 | ||||
| Series A Extension | Nov 1, 2021 | ||||
| Series A | Mar 22, 2018 |
Dracen Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A |
| Osage University Partners | Series A |
| i&i Prague | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 116% MoM, reaching 2K.
- Mar 22, 2018
$41M round led by Deerfield Management.
Dracen Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dracen Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Dracen Pharmaceuticals, Inc. a public or private company?
Dracen Pharmaceuticals, Inc. is a private company.
What is the current stock price of Dracen Pharmaceuticals, Inc.?
Dracen Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Dracen Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dracen Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Dracen Pharmaceuticals, Inc. is not publicly available.
Can I buy Dracen Pharmaceuticals, Inc. stock?
Dracen Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dracen Pharmaceuticals, Inc.'s last funding round?
Dracen Pharmaceuticals, Inc.'s most recent funding round was Debt on July 27, 2023.
Who are the main investors in Dracen Pharmaceuticals, Inc.?
Key investors in Dracen Pharmaceuticals, Inc. include Deerfield Management.
Will Dracen Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Dracen Pharmaceuticals, Inc..
How can I track Dracen Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Dracen Pharmaceuticals, Inc.'s shares on secondary markets.